LNCARSR and renal cell carcinoma: Furthermore, the EV-mediated intercellular transfer of lncARSR enhanced AXL and c-MET expression in renal cell carcinoma cells, which improved sunitinib resistance by competitive interaction with miR-34/miR-449.